We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Incretin Mimetic Can Cause Severe, Disabling Joint Pain, FDA Warns

(August 31, 2015, 2:10 PM EDT) -- SILVER SPRING, Md. — Incretin mimetic diabetes drug Januvia, Onglyza and Tradjenta can cause severe and disabling joint pain, the Food and Drug Administration warned Aug. 28.

In a drug safety...
To view the full article, register now.